Search research articles
Contact Us
Filters
Showing results (841-850 of 1,398) with videos related to
Page
of 140
Sort By:
Nature Cell Biology
|
January 24, 2007
The energy sensing LKB1-AMPK pathway regulates p27(kip1) phosphorylation mediating the decision to enter autophagy or apoptosis
Jiyong Liang, Shan H Shao, Zhi-Xiang Xu, et al.
Nature Medicine
|
October 27, 2004
The RAB25 small GTPase determines aggressiveness of ovarian and breast cancers
Kwai Wa Cheng, John P Lahad, Wen-Lin Kuo, et al.
Bioinformatics (Oxford, England)
|
October 7, 2022
RPPA SPACE: an R package for normalization and quantitation of Reverse-Phase Protein Array data
Huma Shehwana, Shwetha V Kumar, James M Melott, et al.
Cancer Research
|
December 16, 2014
α-Tubulin acetylation elevated in metastatic and basal-like breast cancer cells promotes microtentacle formation, adhesion, and invasive migration
Amanda E Boggs, Michele I Vitolo, Rebecca A Whipple, et al.
Cancer Research
|
April 15, 2010
Mammalian target of rapamycin activator RHEB is frequently overexpressed in human carcinomas and is critical and sufficient for skin epithelial carcinogenesis
Zhi Hong Lu, Mark B Shvartsman, Andrew Y Lee, et al.
Scientific Reports
|
February 14, 2019
Niraparib activates interferon signaling and potentiates anti-PD-1 antibody efficacy in tumor models
Zebin Wang, Kaiming Sun, Yonghong Xiao, et al.
Nature Communications
|
August 30, 2017
Systems analysis of apoptotic priming in ovarian cancer identifies vulnerabilities and predictors of drug response
Ioannis K Zervantonakis, Claudia Iavarone, Hsing-Yu Chen, et al.
Nature Biotechnology
|
July 5, 2022
A multiplex implantable microdevice assay identifies synergistic combinations of cancer immunotherapies and conventional drugs
Zuzana Tatarova, Dylan C Blumberg, James E Korkola, et al.
Cancer Research
|
January 4, 2008
A vascular targeted pan phosphoinositide 3-kinase inhibitor prodrug, SF1126, with antitumor and antiangiogenic activity
Joseph R Garlich, Pradip De, Nandini Dey, et al.
BMC Medicine
|
February 2, 2023
PMCA inhibition reverses drug resistance in clinically refractory cancer patient-derived models
Ki Cheong Park, Jung Min Kim, Sang Yong Kim, et al.
Page
of 140
Search research articles
Search
Showing results (841-850 of 1,398) with videos related to
Sort By:
Page
of 140
Nature Cell Biology
|
January 24, 2007
The energy sensing LKB1-AMPK pathway regulates p27(kip1) phosphorylation mediating the decision to enter autophagy or apoptosis
Jiyong Liang, Shan H Shao, Zhi-Xiang Xu, et al.
Nature Medicine
|
October 27, 2004
The RAB25 small GTPase determines aggressiveness of ovarian and breast cancers
Kwai Wa Cheng, John P Lahad, Wen-Lin Kuo, et al.
Bioinformatics (Oxford, England)
|
October 7, 2022
RPPA SPACE: an R package for normalization and quantitation of Reverse-Phase Protein Array data
Huma Shehwana, Shwetha V Kumar, James M Melott, et al.
Cancer Research
|
December 16, 2014
α-Tubulin acetylation elevated in metastatic and basal-like breast cancer cells promotes microtentacle formation, adhesion, and invasive migration
Amanda E Boggs, Michele I Vitolo, Rebecca A Whipple, et al.
Cancer Research
|
April 15, 2010
Mammalian target of rapamycin activator RHEB is frequently overexpressed in human carcinomas and is critical and sufficient for skin epithelial carcinogenesis
Zhi Hong Lu, Mark B Shvartsman, Andrew Y Lee, et al.
Scientific Reports
|
February 14, 2019
Niraparib activates interferon signaling and potentiates anti-PD-1 antibody efficacy in tumor models
Zebin Wang, Kaiming Sun, Yonghong Xiao, et al.
Nature Communications
|
August 30, 2017
Systems analysis of apoptotic priming in ovarian cancer identifies vulnerabilities and predictors of drug response
Ioannis K Zervantonakis, Claudia Iavarone, Hsing-Yu Chen, et al.
Nature Biotechnology
|
July 5, 2022
A multiplex implantable microdevice assay identifies synergistic combinations of cancer immunotherapies and conventional drugs
Zuzana Tatarova, Dylan C Blumberg, James E Korkola, et al.
Cancer Research
|
January 4, 2008
A vascular targeted pan phosphoinositide 3-kinase inhibitor prodrug, SF1126, with antitumor and antiangiogenic activity
Joseph R Garlich, Pradip De, Nandini Dey, et al.
BMC Medicine
|
February 2, 2023
PMCA inhibition reverses drug resistance in clinically refractory cancer patient-derived models
Ki Cheong Park, Jung Min Kim, Sang Yong Kim, et al.
Page
of 140